Observational studyPloS one2026
Clinical value of the caval-aortic index and inferior vena cava diameter for volume assessment in hypernatremic patients.
Observational study in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAccurate assessment of intravascular volume status in hypernatremic patients presenting to the emergency department is often challenging due to advanced age, altered mental status, and unreliable physical examination. Bedside ultrasonography may provide rapid, noninvasive support for early volume evaluation. This study aimed to assess the clinical utility of inferior vena cava (IVC) diameter and the IVC-to-aorta (IVC/Ao) ratio in relation to early sodium response in patients with hypernatremia.
methodsThis prospective observational study included 60 adult patients with hypernatremia presenting to a tertiary emergency department. Ultrasonographic measurements (IVC diameter, aortic diameter, and IVC/Ao ratio) and manometric measurements (central and peripheral venous pressures) were obtained before fluid resuscitation and repeated at the third hour of treatment. Early sodium response was exploratorily assessed using the 3-hour change in serum sodium (ΔNa1). Receiver operating characteristic analysis was used to determine the optimal ΔNa1 cut-off associated with 30-day mortality.
resultsPatients without early sodium response (n = 42) had significantly higher baseline IVC/Ao ratios than patients with early sodium response (0.74 vs. 0.50, p = 0.037). Ultrasonographic parameters, including baseline and 3-hour IVC diameter and IVC/Ao ratio, demonstrated moderate discriminative performance for predicting early sodium response (AUC range: 0.671-0.683), whereas manometric measurements did not significantly differ between groups. These indices demonstrated high sensitivity but modest specificity for early sodium response.
conclusionIn hypernatremic patients, bedside ultrasound assessment of IVC diameter and IVC/Ao ratio may provide rapid, complementary physiologic information during early volume evaluation. These measurements should be interpreted alongside clinical and laboratory findings rather than as standalone indicators of treatment success.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.